IGFBP4 Antibodies

Santa Cruz Biotechnology features a diverse variety of IGFBP4 monoclonal antibodies for research focused on understanding Insulin-like Growth Factor Binding Protein 4. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).IGFBP4 plays a critical role in regulating the availability and activity of insulin-like growth factors (IGFs), which are essential for cell growth, development, and metabolism. By binding to IGFs, IGFBP4 modulates their effects on cellular processes, influencing growth factor signaling pathways and contributing to various physiological functions. Understanding the dynamics of IGFBP4 is crucial for elucidating its involvement in conditions such as cancer, metabolic disorders, and growth abnormalities. IGFBP4 research has revealed significant insights into cellular regulation and development processes. Ongoing studies continue to uncover new functions and mechanisms of IGFBP4 in different biological systems. Recent findings highlight IGFBP4's importance in tissue regeneration and cellular differentiation. Exploring IGFBP4's role in various pathways has opened new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies for IGFBP4 enable researchers worldwide to advance scientific understanding of growth factor regulation and disease mechanisms.